Gone from iHub.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
About 1/3rd of the people dropped out of the FDA trial before it was complete. Afrezza was a turd, that you couldn't giveaway, long before Sanofi was involved.
Some people think under 18 use is Afrezza's niche. Only two people signed up for the pediatric trial. Only two people in the USA, under 18, were willing to deal with using Afrezza for FREE.
Then, maybe we will finally rise in conjunction to new ship contracts and a full quarter of earnings?
Since the new ships don't arrive for months, I'm skeptical they'll provide much in the way of earnings for the current quarter.
The ships arrive in June, September, October and December of 2017.
Currently the company is relying on toxic financing for cash.
NWBO is an radiant diamond hidden in the pile of useless rocks. However, few people know that it has a tremendous potential and inestimable value.
Is that a good sign?
You can find out:
1. That other similar companies with much larger markets went bankrupt(DNDN).
2. How much is spent total in this area (GBM)
3. How many patients are diagnosed per year
4. How much the company is likely to charge
5. The outstanding share count
etc.
Sounds like something thatmakes perfect sense considering the way that the POG is rising today....BAA
Earlier this year Banro announced their massive giveaway to preferred stockholders. Since then the preferred stock has more than doubled in price. That's what makes perfect sense.
2000 dollars a year ago is worth one dollar today.
It's amazing there are still people rushing to buy.
You must mean the part where the SEC investigates Hedge Funds and friends for paying people to bash certain stocks (NWBO). When I saw this story, I thought the very same thing--what about the other side?
That story is about the management (CEO etc.) of biotech companies hiring promoters to push up the price of their stock and fleece gullible investors.
Read the criminal complaint:
https://www.crowdfundinsider.com/2017/04/98428-sec-takes-action-bogus-articles-pumping-stocks/
That's a horrible article. The timing of the reverse splits has been very predictable.
There are rules about when shares can get issued, and minimum prices in all the toxic financing agreements.
There's no conspiracy related to the fact that people haven't read George's SEC filings.
For example:
The Series E-2 Convertible Preferred Shares are convertible at any time at the option of the holder into common shares at a fixed conversion price of $30.00 per common share; provided, however, that if the volume weighted average price of the common shares on the Nasdaq Capital Market is below $30.00 (subject to adjustment as described herein), then the holder may convert the Series E-2 Convertible Preferred Shares at an alternate price equal to the higher of (x) 85% of the lowest daily volume weighted average price on any trading day during the 21 consecutive trading day period ending on the trading day immediately prior to the conversion date and (y) $1.50. At any time, we may redeem all, but not less than all, of the Series E-2 Convertible Preferred Shares on the terms described in the governing documents.
http://www.marketwatch.com/story/dryships-inc-announces-registered-direct-offering-2016-11-17-91602742
Constant selling of this over the last 30 minutes has driven the price down from 2.36 to 2.23.
DRYS is such an interesting story because there's no arguing about the facts. George is totally open and straightforward about what he's doing. He's been that way since the price used to be more than a million times higher than it is now.
As you can see in the criminal complaint it's a group of biotech stocks that hired paid promoters. The complaint talks about the crooked CEOs and other insiders.
What's a real shame is that most of the articles don't mention the companies or the industry that's so corrupt.
The real problem with these companies, along with Mannkind, is that they waste investor dollars that could, AND SHOULD, go to worthy companies.
IMUC: ImmunoCellular Therapeutics
ADMD: Advanced Medical Isotope Corp
GALE: Galena Biopharma Inc
NBS: Caladrius Biosciences, Inc.
ONCS: OncoSec Medical Inc
etc.
https://www.crowdfundinsider.com/2017/04/98428-sec-takes-action-bogus-articles-pumping-stocks/
Several of the names are in the criminal complaint.
Looks they're all, or mostly, biotech companies.
https://www.crowdfundinsider.com/2017/04/98428-sec-takes-action-bogus-articles-pumping-stocks/
Mannkind Takeover
It's unlikely for two reasons.
1. Many of the shares are held by the Foundation and aren't being traded. So somebody who wanted to buy would have no assurance that they could get control
2. Mannkind explicitly set themselves up to make takeovers very difficult. From their SEC filing.
Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of us, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management.
We are incorporated in Delaware. Certain anti-takeover provisions of Delaware law and our certificate of incorporation and amended and restated bylaws, as currently in effect, may make a change of control of our company more difficult, even if a change in control would be beneficial to our stockholders. Our anti-takeover provisions include provisions such as a prohibition on stockholder actions by written consent, the authority of our board of directors to issue preferred stock without stockholder approval, and supermajority voting requirements for specified actions. In addition, we are governed by the provisions of Section 203 of the Delaware General Corporation Law, which generally prohibits stockholders owning 15% or more of our outstanding voting stock from merging or combining with us in certain circumstances. These provisions may delay or prevent the acquisition of us, even if the acquisition may be considered beneficial by some of our stockholders. In addition, they may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors, which is responsible for appointing the members of our management.
One very nice thing about iHub is they keep all the posting history.
You can go back to when the price was 60 thousand dollars per share and people were claiming it'd fallen so far it was cheap.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=50346777
If you were to screen out the sickest of these patients the statistics would change very little
Screening out the people who have progression days after surgery, and are so sick they can't get move, care for themselves, or get out of bed, doesn't change how long someone is likely to live! Really?
That's the bet you're making by buying this stock.
It sounds like a very bad one to me.
Maybe, just maybe, the toxic financing isn't to catch naked shorts, it's that people don't believe the story this company is telling.
They're both the same thing.
They're both people getting cheated by believing in fake good news and wasting their money on a vastly overpriced stock.
This restructuring has a large impact on the share structure.
Old info (from the iBox) Common Shares Outstanding 302,309,005
New info (from the SEC filing) approximately 1,099,000,000 Common Shares outstanding on an undiluted basis and approximately 1,136,000,000 Common Shares outstanding on a fully-diluted basis.
http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=11811639&RcvdDate=1/31/2017&CoName=BANRO%20CORP&FormType=6-K&View=html
There's roughly 800 million new shares that could be potentially be dumped on the market at any moment.
In the last 10 years Dryships has fallen 94% per year.
301,920 dollars of stock 10 years ago in now worth 70 cents.
Lately George has decided to crush the stock even faster than before. He's really increased his rate of stealing shareholder money to levels never before encountered.
You're exactly right, there's nothing anyone can do about it. If you choose Dryships you have to be prepared.
I posted the results of an FDA trial that includes a lot of information in that regard. It makes fascinating reading.
About 16% of the people lived longer than 1092 days. But of course the DC-VAX1 trial should have a longer survival (more than 3 years) for the control group since they excluded so many of the sickest people.
PMC4070631
p.s. the mean survival recorded is longer than the median survival because of course there's a right-ward tail in the survival distribution.
Just google: cancer expected life span graph
Look for images. There are literally dozens of graphs that show long tails for expected remaining life.
Every serious type of cancer has a long tail for mortality.
There's absolutely nothing unusual about it.
That's true for almost every distribution that you can think of.
Imagine a disease where every day you had it there was a 50/50 chance you'd die. Model it by flipping a coin.
That distribution has a long tail.
50% of the time you'd last one day
25% two days
12.5% three days
1 out of 1000 times you'd last 10 days.
etc.
Long tails are ubiquitous in survival distributions.
This is the long tail:
In my personal opinion there are more people living 1590 days than there are living -406 days.
There are no people in the trial who die before the trial starts.
There are people living long past the mean.
That's obviously true in the control group and the group that takes DC-VAX1.
There are *LOTS* of factors in the trial makeup that ensure that the sickest of patients are not enrolled. That increases the mean survival and the tail.
I don't know how to explain it any clearer, if that's not totally obvious to you.
In any case, at least, the company understands it because they don't even begin to try to persuade people to pay very much for shares.
He posted his tweet at 8:17:
https://stocktwits.com/Ripano/message/79587980
At 8:18am the buying started:
And then all the way up to 1.58 pre-market.
08:59:39 $ 1.38 180
08:59:39 $ 1.38 300
08:59:37 $ 1.38 1,000
08:59:24 $ 1.38 300
08:59:23 $ 1.38 10,000
08:59:20 $ 1.38 300
08:59:19 $ 1.38 2,630
08:59:19 $ 1.38 70
08:59:19 $ 1.38 100
08:59:16 $ 1.38 2,200
08:59:08 $ 1.38 500
08:58:58 $ 1.36 72
08:58:58 $ 1.36 1,500
08:58:16 $ 1.36 2,000
08:56:01 $ 1.36 100
08:56:01 $ 1.36 400
08:56:01 $ 1.36 100
08:55:57 $ 1.36 7,428
08:55:57 $ 1.36 1,472
08:55:57 $ 1.36 100
08:55:55 $ 1.36 1,000
08:53:42 $ 1.36 1,030
08:53:42 $ 1.36 100
08:53:33 $ 1.36 100
08:51:25 $ 1.36 200
08:51:07 $ 1.36 1,200
08:50:56 $ 1.36 9,300
08:50:04 $ 1.36 2,700
08:50:04 $ 1.36 1,800
08:50:04 $ 1.36 200
08:50:04 $ 1.36 200
08:50:04 $ 1.36 100
08:49:28 $ 1.36 1,000
08:48:03 $ 1.36 200
08:48:03 $ 1.36 200
08:48:03 $ 1.36 100
08:48:02 $ 1.35 350
08:42:48 $ 1.36 4,000
08:42:18 $ 1.36 2,000
08:42:18 $ 1.36 451
08:41:15 $ 1.36 1,000
08:40:37 $ 1.36 5,949
08:40:26 $ 1.36 300
08:40:18 $ 1.36 2,000
08:40:09 $ 1.36 200
08:40:09 $ 1.36 100
08:39:07 $ 1.36 500
08:38:50 $ 1.38 900
08:38:48 $ 1.38 100
08:38:48 $ 1.37 100
08:38:18 $ 1.34 100
08:37:36 $ 1.34 100
08:37:36 $ 1.40 1,125
08:37:36 $ 1.36 100
08:37:36 $ 1.35 2,500
08:37:36 $ 1.34 1,175
08:36:35 $ 1.34 2,225
08:36:32 $ 1.34 1,200
08:36:32 $ 1.34 200
08:36:32 $ 1.34 100
08:35:52 $ 1.34 5,000
08:33:28 $ 1.34 2,280
08:32:32 $ 1.34 400
08:32:12 $ 1.34 2,500
08:32:09 $ 1.35 100
08:31:53 $ 1.35 400
08:31:53 $ 1.35 1,500
08:31:53 $ 1.35 100
08:31:12 $ 1.34 100
08:29:18 $ 1.30 100
08:29:18 $ 1.30 861
08:29:17 $ 1.30 9,200
08:29:08 $ 1.30 8,200
08:25:28 $ 1.30 750
08:23:45 $ 1.30 600
08:22:23 $ 1.30 1,000
08:20:23 $ 1.30 5,250
08:19:44 $ 1.30 1,200
08:18:14 $ 1.30 1,139
08:18:14 $ 1.29 Low 185
08:18:14 $ 1.30 76
08:18:14 $ 1.29 Low 100
I don't understand that argument at all.
Nobody with progression OF ANY TYPE is enrolled. That's precisely one of the arguments I made that there should be long tail survivors.
Patients must not have progressive disease at completion of radiation therapy. Patients with suspected pseudoprogression will be enrolled and analyzed separately.
So there really should be no long tail in this GBM trial.
Long before this trial started most people died quickly and a few lived for many many years. That's the long tail.
If the mean survival is 592 are you really suggesting that there's as many people living 2 SD less than the mean as there are living 2 SD more than mean?
In other words do you really believe there as many people living 592 - 2 * 499 as living 592 + 2 * 499 days?
In my personal opinion there are more people living 1590 days than there are living -406 days.
There are varying degrees of disease state within GBM diagnosis
And the sickest of the patients weren't allowed in the trail. And SURPRISE SURPRISE some of the people in the trial are progressing slower than the average patient. And SURPRISE SURPRISE NWBO's only option is to sell very low-priced shares to toxic financiers.
Most importantly the world makes complete sense.
It appears Ripano posted false numbers on StockTwits @817am and that was enough to create this run-up.
Ripano
$MNKD Rx for week ending 3/31/17. I hope all the negative posts will finally stop.
NRx 417
TRx 949
TRx $ 691,000
Outrageous manipulation, and proving once again 100% of manipulation is to up the upside in stocks.
He is a marked man globally...
He's been doing this for over 10 years. On a split adjusted basis the stock used to be in the millions.
If you read his filings, he's actually quite up front about his financial shenanigans.
From this line on the trial:
Patients must have a KPS rating of ≥70 at the baseline visit (Visit 3).
It corresponds to this scale:
http://oncologypro.esmo.org/Guidelines-Practice/Practice-Tools/Performance-Scales
Edit: also from this line on the trial
Patients must not have progressive disease at completion of radiation therapy. Patients with suspected pseudoprogression will be enrolled and analyzed separately.
In general keep in mind that the vast majority of people with this cancer got it from cancer that spread from elsewhere in their body. And many people are too sick to even get surgery.
Both of those groups are not even eligible for taking DC-VAX1.
The middle does not have a long tail on its own.
I've been looking at the research on this and reading the data from clinical trial PMC4070631.
There are 455 (2272/5) people diagnosed per year who received surgery (and met the rest of the criteria).
Their mean survival time is 592 days with a standard deviation of 499 days. In other words there's a huge amount of variability in mean survival.
As we've discussed before NWBO doesn't (or didn't) allow the very sick into their trial. So there's every reason to believe that the mean survival in NCT00045968 is longer than the mean of the entire patient population. And if the mean is greater there's every reason to think that the SD is greater as well.
Obviously a survival distribution with a standard deviation roughly equal to the mean has a tail to the right. It can't have a tail to the left.
After regaining its popularity
This stock used to trade at a, split adjusted, million dollars per share. I think they're suffering from more than a transient loss in popularity.
This might be serious.
No, it's because the toxic financing has a minimum conversion price. So they need to keep rising the price so they can print and sell shares.
I included a screenshot of the sec filing.
I included a link to the SEC filing.
I told you what page it was on.
What more do you want?
It's all here, Dryships is completely truthful.
http://globaldocuments.morningstar.com/DocumentLibrary/Document/f86a859cba7919613673f50db8cabe82.msdoc/original/d7424585_20-f.htm
Did you read about all the toxic financing where lenders can continuously get shares at lower than the market price?
For example:
An additional 50,000 Series E-2 Convertible Preferred Shares were issued upon exercise of our Series E-2 Preferred Warrants (as described below) and our Statement of Designations of the Series E-2 Preferred Shares with respect thereto. The Series E-2 Convertible Preferred Shares were convertible at any time at the option of the holder into common shares at a fixed conversion price of $30.00 per common share; provided, however, that if the volume weighted average price of the common shares on the Nasdaq Capital Market was below $30.00 (subject to adjustment as described herein), then the holder had the option to convert the Series E-2 Convertible Preferred Shares at an alternate price equal to the higher of (x) 85.0% of the lowest daily volume weighted average price on any trading day during the 21 consecutive trading day period ending on the trading day immediately prior to the conversion date and (y) $1.50.
shouldnt market capitalization increase for 200 millions $ when they got the money regardless of pps and float
That's not how companies are valued.
Fully diluted share count * stock price + debt.
I just wanna know why is last 400 millions $ drys raised recently doesn't reflect in market cap
Look at their financial disclosure. You don't have to get beyond the bottom of page two to understand.
http://globaldocuments.morningstar.com/DocumentLibrary/Document/f86a859cba7919613673f50db8cabe82.msdoc/original/d7424585_20-f.htm
ANYONE ELSE GET THE DETAILS?
Creditors get partially paid off. Billions short of the money needed to have any money left over for stockholders.
It's just the standard story. It will never change.
Afrezza sales are about 5 million dollars per year.
The company loses over 100 million per year on those sales.
Loans are coming due in the next few months, and cash is running out.
As I said 4 weeks ago when the stock was at 1.90, things could not be worse. Massive dilution is right around the corner. It's impossible to imagine otherwise.
something just doesnt add up
It does when you read the financial filings.
in February before they raised last 200 millions $ market cap was around 160 millions
You're off by many 100s of millions of dollars.
http://globaldocuments.morningstar.com/DocumentLibrary/Document/f86a859cba7919613673f50db8cabe82.msdoc/original/d7424585_20-f.htm
How many billions of shares do you think were issued as of 12/31/16?
After the reverse split 1 for 8 reverse split how many shares were issued?
How many different kinds of shares does Dryships have?
Dryships has been upfront and honest about their dealings. They've filed SEC documents clearly explaining how little the shares are worth.
NWBO stock is not where it is because of shorts. It's where it is, because it's only source of cash is death spiral financing.
If you want to draw a parallel between DNDN and NWBO feel free. Dendreon's stock was cancelled during its bankruptcy. It ended up totally worthless.
Remember, it only took one false statement about Dendreon by Cramer to drive the PPS on that stock into a downward spiral.
Under a $1 soon then it happens need to meet exchange rule
Recently when the stock fell close to a dollar they did a reverse split because their dilution contract specified the stock had to be above a dollar.
We'll see what happens this time.
An independent journalist reports on a vastly overpriced stock that goes on to crash.
It's the exact same story as here. I first learned about NWBO from Adam. I hesitate to treat him as a hero, I think it's pretty easy to find stocks that have fatal flaws. But he definitely deserves a huge thank you from investors, by allowing them to save their money.
p.s. When I learned about NWBO from Adam, the stock was a LOT HIGHER PRICED than it is now.